Literature DB >> 35298604

CD45: a niche marker for allotransplantation.

Zhanzhuo Li1, Philip M Murphy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35298604      PMCID: PMC8931515          DOI: 10.1182/blood.2021015024

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS.

Authors:  R D Owen
Journal:  Science       Date:  1945-10-19       Impact factor: 47.728

2.  Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin.

Authors:  Rahul Palchaudhuri; Borja Saez; Jonathan Hoggatt; Amir Schajnovitz; David B Sykes; Tiffany A Tate; Agnieszka Czechowicz; Youmna Kfoury; Fnu Ruchika; Derrick J Rossi; Gregory L Verdine; Michael K Mansour; David T Scadden
Journal:  Nat Biotechnol       Date:  2016-06-06       Impact factor: 54.908

3.  Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance.

Authors:  Benson M George; Kevin S Kao; Hye-Sook Kwon; Brenda J Velasco; Jessica Poyser; Angela Chen; Alan C Le; Akanksha Chhabra; Cassandra E Burnett; Devon Cajuste; Malachia Hoover; Kyle M Loh; Judith A Shizuru; Irving L Weissman
Journal:  Cell Stem Cell       Date:  2019-06-13       Impact factor: 24.633

4.  Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer Payload.

Authors:  Arnaud C Tiberghien; Jean-Noel Levy; Luke A Masterson; Neki V Patel; Lauren R Adams; Simon Corbett; David G Williams; John A Hartley; Philip W Howard
Journal:  ACS Med Chem Lett       Date:  2016-05-24       Impact factor: 4.345

5.  A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice.

Authors:  Asim Saha; Sharon Hyzy; Tahirih Lamothe; Katelyn Hammond; Nicholas Clark; Leanne Lanieri; Prashant Bhattarai; Rahul Palchaudhuri; Geoffrey O Gillard; Jennifer Proctor; Megan J Riddle; Angela Panoskaltsis-Mortari; Margaret L MacMillan; John E Wagner; Hans-Peter Kiem; Lisa M Olson; Bruce R Blazar
Journal:  Blood       Date:  2022-03-17       Impact factor: 22.113

6.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

Review 7.  Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma.

Authors:  T A Waldmann
Journal:  Oncogene       Date:  2007-05-28       Impact factor: 9.867

Review 8.  Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2020-08-03

9.  Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation.

Authors:  Zhanzhuo Li; Agnieszka Czechowicz; Amelia Scheck; Derrick J Rossi; Philip M Murphy
Journal:  Nat Commun       Date:  2019-02-06       Impact factor: 14.919

10.  Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.

Authors:  Agnieszka Czechowicz; Rahul Palchaudhuri; Amelia Scheck; Yu Hu; Jonathan Hoggatt; Borja Saez; Wendy W Pang; Michael K Mansour; Tiffany A Tate; Yan Yi Chan; Emily Walck; Gerlinde Wernig; Judith A Shizuru; Florian Winau; David T Scadden; Derrick J Rossi
Journal:  Nat Commun       Date:  2019-02-06       Impact factor: 14.919

  10 in total
  1 in total

1.  The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing.

Authors:  Chengdi Wang; Qiuxiao Yu; Tingting Song; Zhoufeng Wang; Lujia Song; Ying Yang; Jun Shao; Jingwei Li; Yinyun Ni; Ningning Chao; Li Zhang; Weimin Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.